Dr. Brad Stanfield's Decision to Stop NMN

Dr. Brad Stanfield’s Decision to Stop NMN

Dr. Brad Stanfield, a renowned expert in health practices, has recently made a significant decision regarding his own well-being. He has chosen to discontinue the use of NMN, a popular supplement known for its potential benefits in NAD+ metabolism.

NMN, or Nicotinamide Mononucleotide, is a precursor to NAD+, a molecule that plays a crucial role in aging and cancer risk. However, Dr. Stanfield has expressed concerns about the lack of comprehensive knowledge and conflicting findings surrounding NAD+ precursors. He believes that more research is needed to fully understand the implications of these supplements on human health.

As an advocate for longevity strategies, Dr. Stanfield’s approach focuses on addressing the underlying factors that influence NAD+ levels. He believes that eliminating senescent cells, inhibiting CD38, and increasing NAMPT levels are essential steps before considering the use of NAD+ precursors like NMN.

This decision reflects Dr. Stanfield’s commitment to evidence-based health practices and his dedication to staying informed about the latest research in the field. By prioritizing a comprehensive understanding of the complex mechanisms involved in aging and cancer risk, he aims to optimize his own well-being and guide others in making informed choices.

Key Takeaways:

  • Dr. Stanfield has decided to stop taking NMN due to concerns about the lack of knowledge and conflicting studies surrounding NAD+ precursors.
  • He prioritizes addressing underlying factors such as senescent cells, CD38 inhibition, and NAMPT levels before considering NAD+ precursors.
  • His decision reflects his commitment to evidence-based health practices and staying informed about the latest research in the field.
  • Dr. Stanfield’s approach aims to optimize his well-being and provide guidance to others based on comprehensive understanding.

The FDA’s Response to NMN as a Dietary Supplement

The Food and Drug Administration (FDA) has been grappling with the decision of whether to include NMN as a dietary supplement. This deliberation has had far-reaching effects on the market, causing significant disruptions. While the FDA has not yet reached a substantive conclusion on the matter, its ban on the sale of NMN as a supplement has created uncertainty and concern among consumers.

In response to the FDA’s exclusion of NMN as a dietary supplement, a citizen petition was submitted by the Natural Products Association and the Alliance for Natural Health USA. Their petition urged the FDA not to disregard NMN as a valuable dietary supplement. However, the FDA’s lack of substantive response to the petition has left many stakeholders worried and calling for further action.

The FDA’s inaction and lack of a clear decision have caused confusion in the industry and raised questions regarding the future availability of NMN. This indeterminate stance has resulted in retailers, such as Amazon, prohibiting the sale of NMN due to uncertainty surrounding FDA regulations. There are concerns that other sales platforms may follow suit, further limiting the accessibility of this dietary supplement.

It is crucial for the FDA to respond decisively to the citizen petition and provide concrete guidance on NMN as a dietary supplement. Clear regulations and guidelines will not only address the concerns of consumers but also provide clarity and stability to the NMN market. The FDA’s response has the potential to shape the future of NMN as a dietary supplement and influence the decisions of both manufacturers and consumers.

Impact of FDA Decision on NMN as a Dietary Supplement
The FDA’s decision has caused disruptions in the NMN market, leading to uncertainty and concerns about future availability.
Retailers, including Amazon, have prohibited the sale of NMN due to the FDA’s decision.
The lack of a substantive response from the FDA has led to calls for intervention and further action.

The Implications of the FDA’s Decision on NMN Sales

The FDA’s decision to exclude NMN from being defined as a supplement has had significant implications on the NMN market. Previously valued at $280.2 million in the US in 2022, the market for NMN has been greatly impacted by the FDA’s ruling. Retailers, including industry giant Amazon, have already taken action and prohibited the sale of NMN due to the FDA’s decision. This has created uncertainty and concerns among manufacturers, distributors, and consumers alike.

Industry experts predict that other sales platforms may follow suit and also ban the sale of NMN. This would further limit the availability and accessibility of NMN for those who rely on it as a dietary supplement. The lack of a substantive response from the FDA and its apparent prioritization of other matters have raised questions about the future of NMN in the market.

Despite the FDA’s decision, there remains a demand for NMN as a supplement due to its potential health benefits and its popularity among individuals seeking to support their overall well-being. As a result, some consumers may turn to alternative sources or explore overseas options to obtain NMN products. However, this poses its own challenges in terms of quality control, transparency, and regulatory compliance.

The Implications on the NMN Market

To further understand the implications of the FDA’s decision on NMN sales, let’s take a closer look at the market trends and the potential consequences:

Impact Description
Decreased Sales The FDA’s decision has already resulted in decreased sales of NMN products as major retailers have removed them from their shelves.
Reduced Market Competition With fewer retailers offering NMN, the market competition has decreased, limiting choices for consumers.
Potential Increase in Prices The reduced availability and competition may lead to an increase in prices of NMN products from remaining sellers.
Consumer Confusion The FDA’s decision has caused confusion among consumers who were previously relying on NMN as a dietary supplement.

As the NMN market adjusts to the FDA’s decision, industry stakeholders, including manufacturers and distributors, are closely monitoring the situation and exploring potential alternatives to ensure the continued availability of NMN for those who rely on its potential health benefits.

Dr. Stanfield’s Supplement and Medication List

Dr. Brad Stanfield, renowned health expert, has recently shared his personal supplement and medication list, providing valuable insights into his approach to optimizing health and well-being. It is important to note that Dr. Stanfield’s choices are based on his unique circumstances and should not be considered medical advice. Individuals should consult with healthcare professionals before making any changes to their supplement or medication regimens.

Below is a summary of some notable supplements and medications that Dr. Stanfield includes in his daily routine:

  • Collagen: Known for its potential benefits to skin, hair, and joint health.
  • Creatine Monohydrate: Often used by athletes and fitness enthusiasts to enhance physical performance and promote muscle growth.
  • Omega-3 Fatty Acids: Well-documented for their anti-inflammatory properties and potential cardiovascular benefits.

In addition to these supplements, Dr. Stanfield also includes specific medications for his individual needs:

  • Finasteride: Used for its potential ability to address hair loss in certain individuals.
  • Rosuvastatin: A medication commonly prescribed to manage cholesterol levels.

The Importance of Individual Results and Professional Consultation

Dr. Stanfield emphasizes that the efficacy and suitability of supplements and medications may vary from person to person. What works for one individual may not work for another. It is crucial to conduct thorough research and consult with a healthcare practitioner to ensure the appropriate use of supplements and medications.

“While supplements and medications can play a role in supporting overall health, it is essential to approach their use with caution and critical thinking. Consulting with a healthcare professional is crucial for personalized guidance and understanding individual risks and benefits.”

Dr. Stanfield’s supplement and medication list provides valuable insights into his personal approach to health optimization. However, it is important to remember that individual needs may vary, and what works for one person may not work for another. Consulting with a healthcare professional is always recommended to ensure personalized care and safety.

Supplements Dr. Stanfield Plans to Add as He Ages

As Dr. Brad Stanfield approaches the aging process, he has carefully considered his future supplement regimen. One key addition he plans to incorporate is N-acetylcysteine (NAC), a precursor to glutathione. Numerous studies suggest that the glutathione antioxidant system may decline rapidly after the age of 45, making NAC an essential supplement to address age-related declines in glutathione levels. Dr. Stanfield emphasizes the importance of conducting thorough research and awaiting more data before adding NAC to his supplement stack.

Glutathione is a vital antioxidant that plays a crucial role in detoxifying the body and maintaining optimal cellular function. As individuals age, glutathione levels naturally decline, which can lead to an increased vulnerability to oxidative stress and age-related diseases. By supplementing with NAC, which is readily converted into glutathione in the body, Dr. Stanfield aims to support his body’s antioxidant defenses and maintain overall health as he ages.

While Dr. Stanfield acknowledges the potential benefits of NAC supplementation, he advises caution and encourages individuals to consult with healthcare professionals before incorporating any new supplements into their routine. He emphasizes the importance of individualized approaches, as everyone’s health needs and responses to supplements may vary.


Dr. Stanfield’s Stopped Supplements:

Supplement Reason for Stopping
NMN/NR Limited human data and unknown long-term effects
Resveratrol Conflicting research findings and lack of demonstrated benefits in humans
Metformin Insufficient evidence supporting its use in Dr. Stanfield’s health regimen

“I believe in making informed decisions based on the available evidence and research. While these supplements may have potential benefits, the current data did not provide enough certainty for me to continue taking them. It is important to constantly reevaluate and adjust our health practices based on new findings,” says Dr. Stanfield.

Supplements and Medications Awaiting More Data

As Dr. Brad Stanfield continues to explore the world of supplements and medications, there are certain substances that he is excited about but believes require more data before he can confidently recommend them. These include Rapamycin and 17-Alpha Estradiol, both of which have shown promising potential but still need further research.

Rapamycin, a compound derived from bacteria, has demonstrated significant effects on lifespan extension in mice. However, before it can be widely recommended for human use, clinical trials are necessary to assess its safety, efficacy, and potential side effects. While preliminary studies have generated positive results, it is crucial to gather more data to ensure its suitability and long-term effects in humans.

Similarly, 17-Alpha Estradiol, a synthetic hormone derivative, has shown promise in various areas, including neuroprotection and anti-inflammatory effects. However, further research is needed to determine its safety, appropriate dosages, and potential applications in various health conditions. It is essential to establish a comprehensive understanding of 17-Alpha Estradiol before it can be included as part of a well-rounded supplementation regimen.

Supplement/Medication Status Reason
Rapamycin Awaiting Data Promising effects on lifespan extension in mice, but clinical trials needed to assess safety and effectiveness in humans.
17-Alpha Estradiol Awaiting Data Potential benefits, including neuroprotection and anti-inflammatory effects, but further research needed to determine safety and appropriate use in humans.

While these substances hold promise and may have potential benefits, it is essential to await comprehensive data before incorporating them into personal supplementation and medication routines. Dr. Stanfield’s cautious approach underscores the importance of evidence-based decision making when it comes to optimizing health and well-being.

Dr. Stanfield’s Perspective on Stopped Supplements

Dr. Brad Stanfield’s approach to his supplement regimen is driven by personal choice and evidence-based decision-making. He carefully evaluates the available research and scientific literature to ensure that the supplements he includes in his routine are supported by robust data and demonstrate clear benefits. However, Dr. Stanfield also recognizes that scientific understanding is constantly evolving, and he is open to adjusting his choices based on new evidence.

When it comes to stopped supplements, Dr. Stanfield has made informed decisions based on careful consideration of the available research. He believes in prioritizing supplements that have demonstrated efficacy and safety through human studies, while remaining cautious about those with limited evidence or conflicting results. By taking this approach, he aims to optimize his health and well-being while minimizing potential risks or wasted resources.

It is important to note that Dr. Stanfield’s decisions regarding stopped supplements are highly individualized and may not necessarily apply to everyone. Each person’s health profile and goals are unique, and therefore, consulting with a healthcare professional is crucial when making decisions about supplementation. Dr. Stanfield encourages individuals to conduct their own thorough research, seek expert advice, and carefully consider the evidence before incorporating any supplements into their daily routine.


Dr. Brad Stanfield’s decision to stop taking NMN is driven by his concerns regarding the current knowledge and contradictory studies surrounding NAD+ precursors. He recognizes the complex role of NAD+ metabolism in aging and cancer risk, and believes that addressing factors such as senescent cells, inflammation, and NAMPT levels should take precedence over NAD+ precursors in his longevity strategy.

The FDA’s response to NMN as a dietary supplement has been inconclusive, leaving the market in a state of uncertainty. Despite a citizen petition urging the FDA not to exclude NMN, there has been a lack of substantive action. The consequences of the FDA’s decision have already been felt, with major retailers like Amazon prohibiting the sale of NMN. This has raised concerns about the future availability of NMN and its potential impact on health practices.

Dr. Stanfield’s approach to supplementation and medication is rooted in research, individual results, and consultation with healthcare professionals. He believes in making evidence-based decisions and acknowledges that there is still much to learn about the efficacy and safety of various supplements and medications. As he ages, Dr. Stanfield plans to add specific supplements to his regimen, but emphasizes the importance of conducting thorough research and waiting for more data before incorporating them.

Ultimately, Dr. Stanfield’s perspective highlights the need for ongoing research and comprehensive data to make informed decisions about supplements and medications. His approach is guided by a careful evaluation of the available evidence, recognizing that individual experiences and preferences may vary. As the field of longevity continues to evolve, it is essential to prioritize scientific rigor and consultation with healthcare professionals in order to optimize health practices.

Similar Posts